DE60322562D1 - Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik - Google Patents

Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik

Info

Publication number
DE60322562D1
DE60322562D1 DE60322562T DE60322562T DE60322562D1 DE 60322562 D1 DE60322562 D1 DE 60322562D1 DE 60322562 T DE60322562 T DE 60322562T DE 60322562 T DE60322562 T DE 60322562T DE 60322562 D1 DE60322562 D1 DE 60322562D1
Authority
DE
Germany
Prior art keywords
technetium
aza
diaminedioxime
conjugates
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322562T
Other languages
German (de)
English (en)
Inventor
Georg Brauers
Gillian Farrar
David Jonathan Barnett
Harry John Wadsworth
Joanne Sarah Lewis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Application granted granted Critical
Publication of DE60322562D1 publication Critical patent/DE60322562D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60322562T 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik Expired - Lifetime DE60322562D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0224799.7A GB0224799D0 (en) 2002-10-25 2002-10-25 Improved complex compositions
PCT/GB2003/004573 WO2004037297A1 (en) 2002-10-25 2003-10-24 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic

Publications (1)

Publication Number Publication Date
DE60322562D1 true DE60322562D1 (de) 2008-09-11

Family

ID=9946533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322562T Expired - Lifetime DE60322562D1 (de) 2002-10-25 2003-10-24 Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik

Country Status (16)

Country Link
EP (1) EP1553986B1 (enExample)
JP (1) JP2006508084A (enExample)
KR (1) KR20050070080A (enExample)
CN (1) CN1708322A (enExample)
AT (1) ATE402720T1 (enExample)
AU (1) AU2003279444A1 (enExample)
BR (1) BR0315578A (enExample)
CA (1) CA2501684A1 (enExample)
DE (1) DE60322562D1 (enExample)
ES (1) ES2309361T3 (enExample)
GB (1) GB0224799D0 (enExample)
MX (1) MXPA05004418A (enExample)
NO (1) NO20051811L (enExample)
RU (1) RU2005110960A (enExample)
WO (1) WO2004037297A1 (enExample)
ZA (1) ZA200502835B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515974D0 (en) * 2005-08-03 2005-09-07 Ge Healthcare Ltd Compounds and imaging methods
GB0520527D0 (en) * 2005-10-10 2005-11-16 Ge Healthcare Ltd Automated method
GB0614337D0 (en) * 2006-07-19 2006-08-30 Acal Energy Ltd Fuel Cells
US20120165650A1 (en) 2010-12-22 2012-06-28 General Electric Company Her2 binders
ES2804509T3 (es) 2010-07-27 2021-02-08 Serac Healthcare Ltd Composiciones radiofarmacéuticas
RU2013128354A (ru) * 2010-12-21 2015-01-27 ДжиИ ХЕЛТКЕР ЛИМИТЕД Применение анализа в радиостабилизации реакций оксимного лигирования
WO2012085221A1 (en) * 2010-12-22 2012-06-28 Tfchem Derivatives of glyco-cf2-serine and glyco-cf2-threonine
GB201103696D0 (en) * 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
US20130195756A1 (en) * 2012-01-31 2013-08-01 General Electric Company 99mTc IMAGING AGENTS AND METHODS OF USE
GB201610176D0 (en) * 2016-06-10 2016-07-27 Edinburgh Molecular Imaging Ltd Imaging agents and methods of use
CN112830940B (zh) * 2020-09-07 2022-03-01 中国科学院宁波材料技术与工程研究所 2,5-呋喃二甲醛肟金属络合物及其制备方法、及在抗菌除霉消毒剂中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2205186C2 (ru) * 1998-05-15 2003-05-27 Амершам Плк Меченые аналоги глутамина и лизина
JP5043271B2 (ja) * 2000-04-12 2012-10-10 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドベースの化合物
WO2001089584A2 (en) * 2000-05-23 2001-11-29 Amersham Health As Contrast agents
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates

Also Published As

Publication number Publication date
CA2501684A1 (en) 2004-05-06
EP1553986B1 (en) 2008-07-30
RU2005110960A (ru) 2005-11-20
ATE402720T1 (de) 2008-08-15
MXPA05004418A (es) 2005-11-23
ZA200502835B (en) 2006-03-29
NO20051811D0 (no) 2005-04-14
BR0315578A (pt) 2005-10-25
WO2004037297A1 (en) 2004-05-06
GB0224799D0 (en) 2002-12-04
CN1708322A (zh) 2005-12-14
NO20051811L (no) 2005-06-27
ES2309361T3 (es) 2008-12-16
JP2006508084A (ja) 2006-03-09
KR20050070080A (ko) 2005-07-05
EP1553986A1 (en) 2005-07-20
AU2003279444A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
BR0210965A (pt) Conjugado de quelador, complexo de radiometal, radiofármaco, kit para a preparação do mesmo, composto, e, processo para a preparação do mesmo
NO20053754D0 (no) Improved radiometal complex compositions.
Schibli et al. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of 99mTc (I)− tricarbonyl complexes: a hint for the future functionalization of biomolecules
Liu et al. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands
ATE402720T1 (de) Konjugate von tc komplexen und zielgerichtete einheiten und ihre verwendung in nmr-diagnostik
CA2958475C (en) Mono-, di- or oligosaccharide used as metal inhibitors in the preparation of radioactive metal-chelate-functionalized target agents
EA200401285A1 (ru) Меченные радиоактивными изотопами производные хинолина и хинолинона и их применение в качестве лигандов метаботропного глутаматного рецептора
BG108497A (bg) Твърдо-фазно нуклеофилно флуориране
HUP0304083A2 (hu) Radiofarmakon kompozíciók, előállításuk és eljárás radiofarmakonok pufferolására
WO2007042781A3 (en) Automated method for preparing technetium complexes
IL175667A (en) Imaging agent which comrises a synthetic caspase-3 inhibitor labeled with an imaging moiety, a radiopharmaceutical composition comprising the same, a kit for the preparation of said composition and a method of diagnosis based thereon
Liu et al. Synthesis and Characterization of Two 111In-Labeled DTPA− Peptide Conjugates
ATE556722T1 (de) Herstellung von vierzähnigen peptidchelatkonjugaten zur diagnose von kolorektalem krebs
Liu et al. Preparation and properties of 99mTc (CO) 3+-labeled N, N-bis (2-pyridylmethyl)-4-aminobutyric acid
Rattat et al. Comparison of tridentate ligands in competition experiments for their ability to form a [99mTc (CO) 3] complex
BRPI0518636B8 (pt) “kits não-radioativo liofilizado de multi-doses, e, processo para a preparação de múltiplas doses de paciente unitárias do radiofarmacêutico tetrofosmina- 99m tc"
Zhang et al. Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity
TR199802091T2 (xx) Alfa-17 ikame/ katk�lama maddesi i�ermeyen yeni pregnan t�revleri.
DE69723242D1 (de) Ternäre radiopharmazeutische komplexe
WO2007076339A3 (en) Isotopically labelled crosslinking agents for the analysis of protein interactions
Purohit et al. Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules
Thipyapong et al. Insight into technetium amidoxime complex: oxo technetium (V) complex of N-substituted benzamidoxime as new basic structure for molecular imaging
GB0421987D0 (en) Novel technetium and rhenium complexes
NO20055334L (no) Bifunksjonelle tridentate pyrazolylinneholdende ligander for RE og TC trikarbonylkomplekser
WO2003027148A8 (en) Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 1553986

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB